Clinical Trial Update: Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV [Phase 2]

View source ↗

Summary

Phase 2 trial update on inflammatory pathogenesis of coronary atherosclerosis in people living with HIV; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Human Immunodeficiency Virus

Snippet

Sponsor: Johns Hopkins University | Conditions: Coronary Artery Disease, Human Immunodeficiency Virus | Phase 2 | Status: COMPLETED | Results posted: 2021-08-19